Devroe Eric
SEC insider (Form 3/4/5 filer). CIK 0001950573. Chief Operating Officer at Acrivon Therapeutics, Inc. (ACRV). 13 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WATERTOWN, MA.
Companies Devroe Eric has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Officer, Chief Operating Officer
Devroe Eric
CIK: 0001950573
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Acrivon Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 18, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect604 shares at avg. $2.01$1K - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect73K shares- - May 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect613 shares at avg. $1.92$1K - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
186.7K shares- - Feb 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect723 shares at avg. $1.63$1K - Jan 13, 2026ACRV
Acrivon Therapeutics, Inc.
PurchaseDirect10K shares at avg. $1.72$17K - Nov 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect613 shares at avg. $2.24$1K - Aug 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect613 shares at avg. $1.39$852.07 - May 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect613 shares at avg. $1.14$698.82 - Mar 1, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
140.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 604 | $2.01 | $1,214 | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 72,981 | - | $0 | Direct |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 613 | $1.92 | $1,177 | Direct |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 186,728 | - | - | Direct |
| Feb 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 723 | $1.63 | $1,178 | Direct |
| Jan 13, 2026 | ACRV Acrivon Therapeutics, Inc. | Purchase | 10,000 | $1.72 | $17,218 | Direct |
| Nov 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 613 | $2.24 | $1,373 | Direct |
| Aug 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 613 | $1.39 | $852 | Direct |
| May 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 613 | $1.14 | $699 | Direct |
| Mar 1, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 140,540 | - | - | Direct |
1-10 of 13 transactions